Fevertree Bulls Return to Soothe Concerns Over Silent November
- Results could still beat analyst estimates: Morgan Stanley
- Shares gain for a second day, paring November’s decline
This article is for subscribers only.
After a rough few months for Fevertree Drinks Plc, bullish analysts haven’t lost the faith.
Morgan Stanley and Jefferies both published positive notes on Friday, shrugging aside the absence of a customary November guidance upgrade that led the U.K. premium tonic maker’s shares to erase gains for the year.